Skip to main content

PTC Symptoms Lead to Filing of Mirena IUD Lawsuit

PTC Symptoms Lead to Filing of Mirena IUD Lawsuit

PTC Symptoms Lead to Filing of Mirena IUD Lawsuit

Introduction

An increasing number of product liability lawsuits are filed against Bayer Healthcare, the maker of intrauterine birth control device Mirena. The lawsuits are filed by women who allege that the intrauterine device (IUD) maker failed to adequately warn the medical community and the end users about the associated risks.

Recently, a lawsuit was filed in the U.S. District Court for the Southern District of New York by a woman who raised similar allegations that the side effects of Mirena IUD caused blurred vision, severe headaches, back pains and other symptoms related to pseudotumor cerebri (PTC), or idiopathic intracranial hypertension (IIH) (a medical condition involving a dangerous build-up of fluid pressure around the brain) for which she had to be hospitalized and also undergo a diagnostic lumbar puncture .

A similar complaint was filed by a woman from Ohio in the U.S. District Court for the Southern District of New York, who claims the Mirena implant caused a dangerous build-up of fluid pressure on her optic nerves, resulting in papilledema, light sensitivity, blurred vision, headaches and other complications leaving her with a permanent injury.

This case will join the 200 plus centralized lawsuits involving pseudotumor cerebri or intracranial hypertension complications from Mirena IUDs filed against Bayer Healthcare as a part of MDL: 2767, established in April 2017, for coordinated pre-trial proceedings in the Southern District of New York, before Judge Paul A. Engelmayer.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!